FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

16591311000001105: Canakinumab 150mg powder for solution for injection vials 1 vial (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Feb 2010. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
58003701000001111 Canakinumab 150mg powder for solution for injection vials 1 vial (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
58003801000001119 Canakinumab 150mg powder for solution for injection vials 1 vial en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Canakinumab 150mg powder for solution for injection vials 1 vial Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Canakinumab 150mg powder for solution for injection vials 1 vial Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Canakinumab 150mg powder for solution for injection vials 1 vial Has VMP Canakinumab 150mg powder for solution for injection vials true Inferred relationship Existential restriction modifier
Canakinumab 150mg powder for solution for injection vials 1 vial VMP prescribing status (attribute) VMP not recommended to prescribe - patient training required false Inferred relationship Existential restriction modifier
Canakinumab 150mg powder for solution for injection vials 1 vial VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
Canakinumab 150mg powder for solution for injection vials 1 vial Has specific active ingredient Canakinumab false Inferred relationship Existential restriction modifier
Canakinumab 150mg powder for solution for injection vials 1 vial Has dispensed dose form Powder for conventional release solution for injection true Inferred relationship Existential restriction modifier
Canakinumab 150mg powder for solution for injection vials 1 vial Has specific active ingredient Canakinumab true Inferred relationship Existential restriction modifier
Canakinumab 150mg powder for solution for injection vials 1 vial VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
Canakinumab 150mg powder for solution for injection vials 1 vial VMP prescribing status (attribute) Caution - AMP level prescribing advised true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Ilaris 150mg powder for solution for injection vials (Novartis Pharmaceuticals UK Ltd) 1 vial Is a True Canakinumab 150mg powder for solution for injection vials 1 vial Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start